1. BSE:524715 • NSE:SUNPHARMA Bloomberg: SUNP@IN • Reuters: SUN.BO www.sunpharma.com Creating Lasting Value Investor Presentation - August 2013 2. Creating Lasting Value…

Delft University of Technology Parallel and Distributed Systems Report Series An Analysis of Provisioning and Allocation Policies for Infrastructure-as-a-Service Clouds:…

Technical Report NetApp Thin Provisioning Deployment and Implementation Guide Data ONTAP 8.1 7-Mode Carlos Alvarez, NetApp September 2011 | TR-3965 | Rev. 1 ABSTRACT This…

Slide 1Ranbaxy Laboratories Limited Merrill Lynch 12 th India Investor Conference New Delhi, February 2008 Slide 2 Safe Harbor Except for the historical information contained…

Slide 1The Challenge from India Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited, Delhi, India Lisbon – 8/9 November…

Slide 1 Investor Presentation | April 2015 BSE CODE : 524558 | NSE SYMBOL : NEULANDLAB | BLOOMBERG: NLL:IN | REUTERS: NEUL.NS © 2015 – Neuland Laboratories Limited. All…

Slide 1 The Challenges from India in the Global Generic Market Place Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited,…

Slide 1 The Opportunities & Challenges from India Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited, Delhi, India…

Slide 1 Cross Cultural Workforce Engagement Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited, Delhi, India Human Resources…

Slide 1 Ranbaxy Laboratories Limited To become a Research based International Pharmaceutical Company UBS Global Generic and Specialty Pharmaceuticals Conference New York…